TY - JOUR A1 - Koeder, Christian A1 - Alzughayyar, Dima A1 - Anand, Corinna A1 - Kranz, Ragna-Marie A1 - Husain, Sarah A1 - Schoch, Nora A1 - Hahn, Andreas A1 - Englert, Heike T1 - The healthful plant-based diet index as a tool for obesity prevention – the Healthy Lifestyle Community Program cohort 3 study JF - Obesity Science and Practice N2 - Background Worldwide the prevalence of obesity is high, and promoting a shift towards more healthful and more plant-based dietary patterns appears to be one promising strategy to address this issue. A dietary score to assess adherence to a healthy plant-based diet is the healthful plant-based diet index. While there is evidence from cohort studies that an increased healthful plant-based diet index is associated with improved risk markers, evidence from intervention studies is still lacking. Methods A lifestyle intervention was conducted with mostly middle-aged and elderly participants from the general population (n = 115). The intervention consisted of a 16-month lifestyle program focusing on a healthy plant-based diet, physical activity, stress management, and community support. Results After 10 weeks, significant improvements were seen in dietary quality, body weight, body mass index, waist circumference, total cholesterol, measured and calculated LDL cholesterol, oxidized LDL particles, non-HDL cholesterol, remnant cholesterol, glucose, insulin, blood pressure, and pulse pressure. After 16 months, significant decreases were seen in body weight (-1.8 kg), body mass index (-0.6 kg/m2), and measured LDL cholesterol (-12 mg/dl). Increases in the healthful plant-based diet index were associated with risk marker improvements. Conclusions The recommendation of moving towards a plant-based diet appears acceptable and actionable and may improve body weight. The healthful plant-based diet index can be a useful parameter for intervention studies. Y1 - 2022 U6 - http://dx.doi.org/10.1002/osp4.649 ER - TY - JOUR A1 - Kranz, Ragna-Marie A1 - Englert, Heike T1 - Entwicklung des Lebensstilprogramms „Gemeinsam Gesund“ JF - Prävention und Gesundheitsförderung N2 - Zusammenfassung Hintergrund. Zivilisationserkrankungen (NCD) werden in Deutschland mit nahezu allen Sterbefällen assoziiert. Durch einen gesunden Lebensstil lässt sich das Erkran-kungsrisiko jedoch maßgeblich beeinflussen. Daraus leitet sich ein großes Potenzial für Lebensstilinterventionen zur Prävention und Gesundheitsförderung ab. Das community-basierte Lebensstilprogramm „Gemeinsam Gesund“ kombiniert verhaltens- und verhältnispräventive Maßnahmen zur NCD-Prävention. Fragestellung. Wie lässt sich das Programm „Gemeinsam Gesund“ mithilfe des Interven-tion-Mapping-Ansatzes (IMA) entwickeln und strukturieren? Methodik. Die Planung des Lebensstil-programms erfolgte mithilfe des IMA. Die theoretische Planungsmethode ermög-lichte eine in Teilschritte untergliederte Programmentwicklung, die von einer Analyse der Ausgangssituation und Zielfindung über die Maßnahmenfestlegung bis hin zur Evaluationsplanung reichte. Ergebnisse. Die Bedarfs- und Bestandsanalyse (Schritt I) konnte die Bedarfe und bereits eta-blierte Gesundheitsangebote der Community aufzeigen. Daraus konnten konkrete Ziele ent-wickelt (Schritt II) sowie Maßnahmenformate und -inhalte (Schritt III) festgelegt werden. Es wurden Gesundheitschecks und ein 10-wöchiges intensives Lebensstilprogramm mit anschließenden Alumni-Treffen konzipiert. Für alle Interventionsinhalte wurden Materialien entwickelt (Schritt IV) und die Akteure für die Implementierung vor Ort identifiziert (Schritt V). Für die Evaluation (Schritt VI) wurde eine Kombination aus einer Effekt- und Prozessevaluation geplant. Diskussion. Der IMA eignet sich gut zur Planung von komplexen Lebensstilprogram-men. Die Anwendung der Methode konnte zu einer sehr zielgruppenorientierten Inter-ventionsentwicklung beitragen, wenngleich einige Abweichungen von der normalen Vorgehensweise des IMA notwendig waren. KW - Prävention; Gesundheitsförderung; Intervention-Mapping-Ansatz; Interventionsentwicklung; Community Y1 - 2020 U6 - http://dx.doi.org/10.1007/s11553-020-00759-z SP - 1 EP - 7 ER - TY - JOUR A1 - Kranz, Ragna-Marie A1 - Kettler, Carmen A1 - Anand, Corinna A1 - Koeder, Christian A1 - Husain, Sarah A1 - Schoch, Nora A1 - Buyken, Anette A1 - Englert, Heike T1 - Effect of a controlled lifestyle intervention on medication use and costs: The Healthy Lifestyle Community Program (cohort 2) JF - Nutrition and Health N2 - Background: Establishing a healthy lifestyle has a great potential to reduce the prevalence of non-communicable diseases (NCDs) and their risk factors. NCDs contribute immensely to the economic costs of the health care system arising from therapy, medication use, and productivity loss. Aim: The aim of this study was to evaluate the effect of the Healthy Lifestyle Community Program (cohort 2; HLCP-2) on medication use and consequently on medication costs for selected NCDs (diabetes, hypertension, and dyslipidemia). Methods: Data stem from a 24-month non-randomised, controlled intervention trial aiming to improve risk factors for NCDs. Participants completed questionnaires at six measurement time points assessing medication use, from which costs were calculated. The following medication groups were included in the analysis as NCD medication: glucose-lowering medications (GLM), antihypertensive drugs (AHD) and lipid-lowering drugs (LLD). Statistical tests for inter- and intra-group comparison and multiple regression analysis were performed. Results: In total, 118 participants (intervention group [IG]: n = 79; control group [CG]: n = 39) were considered. Compared to baseline medication use decreased slightly in the IG and increased in the CG. Costs for NCD medication were significantly lower in the IG than in the CG after 6 (p = 0.004), 12 (p = 0.040), 18 (p = 0.003) and 24 months (p = 0.008). After multiple regression analysis and adjusting for confounders, change of costs differed significantly between the groups in all final models. Conclusion: The HLCP-2 was able to moderately prevent an increase of medication use and thus reduce costs for medication to treat NCDs with the greatest impact on AHD. Y1 - 2023 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:hbz:836-opus-162176 SN - 2047-945X PB - Sage Publications ER -